Catalyst Wire Dossier Catalyst Wire Dossier

Gotenfia

golimumab · Stada Arzneimittel AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Gotenfia, covering 2026-02-25 to 2026-07-01. Get the full timeline:

Most recent: EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG

See pricing